Our study extends this paradigm by demonstrating significant PKP2 downregulation across multiple post‐myocardial infarction HF models, suggesting its potential role as a molecular mediator in acquired cardiac pathologies beyond its established genetic associations. The gene discussed is PKP2; the disease is myocardial infarction.